Hits: 0
WPCNR Westchester County Clarion-Eagle, From WC Department of Communications and John F. Bailey. June 10, 2002. 11:15 E.D.T. UPDATED 4:30 PM E.D.T>: Five leading developers who submitted “excellent” preliminary proposals will now vie to design and build Westchester’s new medical research park on a 60-acre site at Grasslands, according to an official announcement. The finalist is expected to be announced this fall.
Ms. Lyn Bedell, spokesperson for the Westchester County Department of Communications, told WPCNR, it was premature to consider the nature of the research which would be conducted by future tenants. She said, “we’re not into specifics (of research) at this time. We’re primarily looking at proposals and the design of the buildings.”
Ms. Bedell said the county would lease the Grasslands property to the selected developer, and said she would check for WPCNR to see if the County planned to set limits on what kinds of research could be conducted by tenants of the developer selected.
Bedell told WPCNR Monday afternoon, that there were no plans at this time for the county to stipulate what kinds of research would be acceptable at the proposed facility. She said she assumed the county would “not permit anything dangerous.” She did not rule out the county forumulating guidelines as to “acceptable research” once the developer is selected.
The American Health Foundation is currently planning to be a major tenant at the proposed Grasslands facility, she said.
The American Health Foundation specializes in cancer research and preventive medicine, according to their website, www.ahf.org.
Formal Proposals Coming Up.
Each of the firms or partnerships, who already submitted their qualifications and made some preliminary suggestions, will soon be invited to prepare formal proposals detailing exactly how they would develop the property. The proposals will be reviewed by an ad-hoc committee organized by the Westchester County Office of Economic Development and a final developer should be selected by September.
Spano Enthusiastic About Westchester Appeal for Biotech Development.
“This project has generated an amazing amount of enthusiasm,” said County Executive Andy Spano. “When we set out to see who was interested, we were hoping to come up with two or three qualified firms or development teams. The fact that we ended up with five – all of whom submitted excellent proposals – says a lot about the potential of this project.”
Westchester County is working with the Westchester Medical Center, New York Medical College and New York State Empire State Development to develop up to 1 million square feet of lab and incubator space on a county-owned site next to the hospital in Valhalla. The plan is to attract well established companies as anchor tenants, as well as small and start-up medical and biotechnology firms.
Financial Arrangements in the Millions Being Suggested: Carrera
Salvatore J. Carrera, head of the county’s Office of Economic Development/Real Estate, said the developers have already made a number of suggestions and indicated what type of business arrangement the county might be able to work out. The complex would generate millions of dollars in income for the county as well as hundreds of new jobs.
“The developers gave us more information than we asked for,” Carrera said. “Some provided additional information about the financial viability of the site – which was encouraging. They also addressed prospective ground rents and the actual development of the property, which would come into play when they submit formal proposals.”
Designs Suggest Cluster Buildings
So far ideas range from a campus environment with clusters of 20,000-square-foot buildings connected by atriums and common areas to a core lab facility surrounded by satellite support offices. One noted that the buildings would certainly include amenities such as fitness rooms, teleconference centers and auditoriums equipped with the latest technology.
Thumbnail Profiles of Biotech Developers:
• Tishman Urban Development Corporation of New York City, an affiliate of Tishman Realty & Construction Co., which developed E Walk, a large retail/entertainment center on 42nd Street in Manhattan, and oversaw the restoration of the New Amsterdam Theatre.
• Mack-Cali Realty Corporation, headquartered in Cranford, NJ. One of the nation’s leading real estate investment trusts, Mack-Cali owns and manages over 28 million square feet of office properties, primarily in the Northeast. The firm is currently developing several business parks.
• Lyme Properties & MetroNexus , of Boston and New York City. These development partners have designed and developed biotechnology and medical research facilities for clients such as Bristol Myers Squibb, Eli Lilly, Merck, Pfizer and Vertex. Principals of MetroNexus, a real development company, developed, managed and financed over $3 billion in development in the U.S., including AvalonBay Communities in New Rochelle, Bronxville and Mamaroneck.
• LCOR and HRH Construction. The New York City-based LCOR is the owner/operator of the Landmark at Eastview, one of the largest multi-tenanted science parks in the county, and is now constructing Bank Street Commons in White Plains. HRH served as construction manager for several Memorial Sloan Kettering research laboratories as well as the New York State Psychiatric Institute.
• Reckson Associates, a real estate investment trust which owns over 200 properties in the tri-state area (35 in Westchester and Fairfield counties). Reckson built research and development space for Grumman and other blue chip defense and technology companies, and is currently constructing a 39-acre business park next to MacArthur Airport on Long Island.
Centerpiece of County Executive’s development Plan
The research park is a key component in Spano’s economic development efforts, which include strengthening and expanding the biotechnology and research sector. With about 8,000 employees, Westchester already has the state’s largest concentration of biotech and pharmaceutical workers. The research park site is conveniently located within a nucleus of biotechnology and pharmaceutical firms and close to New York Medical College and the American Health Foundation, as well as the medical center.